1. Chapter 36
Vaccines
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

2. Immunity Active immunity Acquired immunity Passive immunity
Body produces antibodies.
Natural immunity
Acquired immunity
Exposed to antigen
Passive immunity
Receives antibodies from another source
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

3. Vaccines Antigen Attenuated virus Toxoids Conjugate vaccines
Recombinant subunit vaccines
Adjuvant
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

4. Examples of Vaccine Preventable Diseases
Anthrax
Diphtheria
Haemophilus influenzae type B (Hib)
Hepatitis
Human papillomavirus
Influenza
Japanese encephalitis
Measles
Meningococcal disease
Mumps
Pertussis
Pneumococcal disease
Poliomyelitis
Rabies
Rotavirus
Rubella
Smallpox
Tetanus
Tuberculosis
Typhoid
Varicella
Yellow fever
Zoster
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

5. Childhood Immunizations
Centers for Disease Control and Prevention (CDC)
Recommendation for childhood immunizations:
Immunization Action Coalition
Summary of rules for childhood immunizations:
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

6. Adult Immunizations Centers for Disease Control and Prevention (CDC)
Recommendation for adult immunizations:
Immunization Action Coalition
Summary of rules for adult immunizations:
Cocooning
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

7. Immunization Before Foreign Travel
All immunizations indicated based on age and/or immunization history
Typhoid
Yellow fever
Meningococcal disease
Rabies
Japanese encephalitis
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

8. Reporting of Disease and Adverse Reactions
All health care providers responsible for reporting vaccine-preventable diseases 
Contraindications for vaccines
Report adverse reactions (VAERS):
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

9. Varicella Vaccine Pharmacodynamics Contraindications
Mode of action/therapeutic effects
Drug interactions
Side effects/adverse reactions
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

10. Future of Vaccines Anthrax: www.anthrax.osd.mil Smallpox
Pertussis: Adacel, Boostrix
Herpes zoster: Zostavax
Rotavirus: RotaTeq
Human papillomavirus: Gardasil
Pneumococci: Prevnar
Neisseria meningitides and Haemophilus influenza type B: Menhibrix
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

11. Nursing Process: Vaccines
Assessment
Nursing diagnoses
Planning
Nursing interventions
Patient teaching
Cultural considerations
Evaluation
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

12. Practice Question #1
A patient receives a vaccine that contains components of an inactivated (killed) microorganism. The nurse identifies the type of vaccine as
traditional vaccine.
attenuated virus.
toxoid.
recombinant subunit vaccine.
Answer: A
Rationale: Traditional vaccines contain the whole or components of an inactivated (killed) microorganism. Other vaccines are attenuated viruses composed of live, attenuated (weakened) microorganisms. Toxoids are inactivated toxins, the harmful disease-causing substance produced by some microorganisms. Recombinant subunit vaccines involve the insertion of some of the genetic material (e.g., deoxyribonucleic acid [DNA]) of a pathogen into another cell or organism, where the antigen is then produced in massive quantities. These antigens are then used as a vaccine in place of the whole pathogen.
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

13. Practice Question #2
A physically and medically neglected 15-month-old child has been placed in foster care. The foster parents bring the child to the clinic for immunization updates. They have no idea what, if any, vaccines the child has previously received. The nurse anticipates administering which vaccines?
No vaccines; assume the child is up to date
DTaP #4, Hib #4, and MMR #1
MMR, IPV, PCV, hepatitis B, and varicella
DTaP, Hib, hepatitis B, MMR, IPV, PCV, and varicella
Answer: D
Rationale: Recommended vaccines for children are diphtheria-tetanus-acellular pertussis, inactivated polio, varicella, measles-mumps-rubella, Haemophilus influenzae type B, hepatitis A, hepatitis B, pneumococcal conjugate, influenza, meningococcal conjugate, human papillomavirus, and rotavirus.
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

14. Practice Question #3
The procedure of immunizing adults in close contact with newborns and young infants to protect the babies from contracting vaccine-preventable diseases in the months before they are eligible to receive the vaccine themselves is called
swaddling.
isolating.
stabilizing.
cocooning.
Answer: D
Rationale: A strategy called cocooning focuses on immunizing adults in close contact with newborns and young infants to protect the babies from contracting vaccine-preventable diseases in the months before they are eligible to receive the vaccine themselves.
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

15. Practice Question #4
Newborns receive immunities via the transfer of maternal antibodies across the placenta. This is known as
natural, passive immunity.
acquired, passive immunity.
natural, active immunity.
acquired, active immunity.
Answer: A
Rationale: Passive immunity occurs when an individual receives antibodies against a particular pathogen from another source. Newborn infants naturally receive passive immunity via the transfer of maternal antibodies across the placenta. Passive immunity may also be acquired through the administration of antibodies pooled from several human or animal sources that have been exposed to disease-causing pathogens.
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

16. Practice Question #5
Before administering the varicella vaccine, it is most important for the nurse to assess the patient for a history of allergy to
penicillin.
eggs.
neomycin.
milk.
Answer: C
Rationale: Varicella vaccine should be avoided in patients with a history of previous anaphylaxis to this vaccine or to any of its components, including gelatin and neomycin. It is also contraindicated in the presence of moderate to severe acute illness or active untreated tuberculosis.
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

17. Practice Question #6
Which statement about Zostivax does the nurse identify as being true?
Zostivax is indicated for the treatment of patients at age 40 years.
Zostivax is a live attenuated vaccine.
Zostivax should be administered every other year.
Zostivax prevented the development of zoster in 90% of the people who received the vaccine.
Answer: B
Rationale: Zostivax is a live attenuated vaccine. Zostavax is licensed for use as a one-time injection in adults age 50 years and older. The vaccine has been shown to boost VZV immunity among vaccine recipients. In clinical trials, Zostavax prevented zoster in about 50% of people who received the vaccine. Effectiveness appears to decrease with increasing age of the vaccine recipient. In those who received the vaccine yet went on to develop zoster, the duration of pain was reduced.
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.

18. Practice Question #7
Which is the first vaccine developed to prevent cancer?
RotaTeq
Prevnar
Menhibrix
Gardasil
Answer: D
Rationale: Gardasil, the human papillomavirus (HPV) vaccine, has been called the first vaccine designed to prevent cancer. Prevnar is the first pneumococcal conjugate vaccine, which provides protection against seven serotypes of pneumococci. Menhibrix, a combination vaccine for infants and children age 6 weeks through 18 months, is used for prevention of invasive disease caused by Neisseria meningitides and Haemophilus influenza type b. Rotavirus is a leading cause of severe acute gastroenteritis in infants and young children. RotaTeq, a live oral vaccine containing five strains of rotavirus, is effective in protecting against severe gastroenteritis and significantly reduces the need for hospitalization among infected children.
Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.